“A Public-Private Partnership for Drug Discovery” – Read the Latest Blog Post from ASBMR Scientific Web Editor Dr. Joe Lorenzo
Date: February 12, 2014
In his latest blog post, ASBMR Scientific Web Editor Dr. Joe Lorenzo argues that a more efficient drug discovery process is needed. Lorenzo states that it has been reported that as many as 95 percent of the drugs in development are ultimately rejected because they lack clinical efficacy or have unacceptable side effects. This has recently led to a number of expensive failures of drugs in phase III clinical trials, which can each cost as much as one billion dollars (US). Read Dr. Lorenzo’s full blog post on the ASBMR website.